FDA 483 - Logix Biosciences Inc. - August 11, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Logix Biosciences Inc., an own-label distributor in Monterey, CA, received a Form 483 with two observations. The inspection revealed deficiencies in the firm's quality control unit responsibilities, including an inadequate quality agreement with its contract manufacturer, leading to a lack of reserve sample reviews and annual product reviews. Additionally, the firm's stability program for drug products was found to lack reliable test methods to identify degradation products and assess environmental effects.
ID · 7447b499-5a8c-4f5c-97c3-9975702159d7